Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Iron Chelating Agents/administration & dosage/adverse effects/*therapeutic use"'
Autor:
Diyar Z. Akkaynak, Yeşim Oymak, Gonul Aydogan, Tuğba Gürleyen Eren, Gülsün Karasu, Bahattin Tunç, Fatma Gumruk, Selma Unal, Umran Caliskan, Turkan Patiroglu, Adalet Meral Güneş, Zafer Salcioglu, Ahmet Koç, Yusuf Ziya Aral, Yasemin Isik Balci, Mehmet Akin, Aylin Canbolat Ayhan, Vedat Uygun, Osman Alphan Küpesiz, Gönül Oktay, Canan Vergin, Betül Biner, İlgen Şaşmaz, Mehmet Ertem, Hilmi Apak, Emine Türkkan, Yıldız Yildirmak, Cetin Timur, Elif Güler Kazanci, Gülersu Irken, Ülker Koçak, Murat Söker, Erdal Kurtoğlu, Mehmet Akif Yesilipek, Bülent Antmen, Zeynep Karakas
PubMedID: 30300449 Objectives: To evaluate the long-term efficacy and safety of deferasirox therapy in a large observational cohort of children with transfusion-dependent thalassemia (TDT) and sickle cell anemia (SCA) in Turkey. Methods: This was a m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b5a731b446ddb4e25ef6dbad909d7cf
